The Discounted Cash Flow (DCF) valuation of Can Fite Biopharma Ltd (CANF.TA) is (12,344.18) USD. With the latest stock price at 1.20 USD, the upside of Can Fite Biopharma Ltd based on DCF is -1028781.8%.
Based on the latest price of 1.20 USD and our DCF valuation, Can Fite Biopharma Ltd (CANF.TA) is a sell. selling CANF.TA stocks now will result in a potential gain of 1028781.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 7.1% | 6.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (39,167.83) - (7,365.13) | (12,344.18) |
| Upside | -3264086.2% - -613860.8% | -1028781.8% |